Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Agenda of the PRAC meeting 24 - 27 November 2025

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 28, Status: Authorised

PSUSA/00002510/202501

List of signals discussed at PRAC since September 2012

PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC meeting

PSUSA/00003045/202501

Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised